| Affiliation: | 1. Biomunex Pharmaceuticals, 75116 Paris, France;2. Morse Consulting, 75016 Paris, France;3. Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02129, United States;1. Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany;2. Comprehensive Cancer Center Mainfranken, Universitätsklinikum Würzburg, Würzburg, Germany;1. Department of Medical Oncology, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands;2. Division of Cell Biology, Department of Biology, Faculty of Science, Utrecht University, Padualaan 8, 3584 CH Utrecht, The Netherlands;1. Gustave Roussy Cancer Campus, Department of Pharmacology, Villejuif, F-94805, France;2. University Paris-Saclay, Faculty of Pharmacy, Chatenay-Malabry, F-92290, France;3. Gustave Roussy Cancer Campus, Laboratory of Immunomonitoring in Oncology, Villejuif, F-94805, France;4. Gustave Roussy Cancer Campus, Department of Ambulatory Care, Villejuif, F-94805, France |
